Andrew Galler's Stock Ratings

Morgan Stanley Analyst

Andrew Galler is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/15/2025

Overall Average Return

-16.6%

Smart Score

33.5%

Overall Average Return Percentile

16th

Number of Ratings

29
Buy NowGet Alert
03/07/2025IMCRBuy Now
Immunocore Holdings
$26.9230.01%
Andrew Galler33%
$35 → $35Assumes → Equal-WeightGet Alert
12/13/2024IMCRBuy Now
Immunocore Hldgs
$26.9230.01%
Andrew Galler33%
$74 → $35DowngradeOverweight → Equal-WeightGet Alert
10/11/2024IMCRBuy Now
Immunocore Hldgs
$26.92174.89%
Andrew Galler33%
$80 → $74MaintainsOverweightGet Alert
11/09/2023FOLDBuy Now
Amicus Therapeutics
$7.05112.83%
Andrew Galler33%
$14 → $15MaintainsEqual-WeightGet Alert
10/10/2023FOLDBuy Now
Amicus Therapeutics
$7.0598.64%
Andrew Galler33%
$15 → $14MaintainsEqual-WeightGet Alert
08/01/2023IMCRBuy Now
Immunocore Hldgs
$26.92193.46%
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
07/31/2023IMCRBuy Now
Immunocore Hldgs
$26.92193.46%
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
07/24/2023IMCRBuy Now
Immunocore Hldgs
$26.92193.46%
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
07/17/2023IMCRBuy Now
Immunocore Hldgs
$26.92193.46%
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
07/11/2023IMCRBuy Now
Immunocore Hldgs
$26.92193.46%
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
07/11/2023FOLDBuy Now
Amicus Therapeutics
$7.05112.83%
Andrew Galler33%
$15 → $15ReiteratesEqual-Weight → Equal-WeightGet Alert
06/26/2023IMCRBuy Now
Immunocore Hldgs
$26.92193.46%
Andrew Galler33%
$79 → $79ReiteratesOverweight → OverweightGet Alert
06/12/2023IMCRBuy Now
Immunocore Hldgs
$26.92193.46%
Andrew Galler33%
 → $79Reiterates → OverweightGet Alert
12/09/2022SLNBuy Now
Silence Therapeutics
$2.71564.21%
Andrew Galler33%
 → $18Initiates → Equal-WeightGet Alert
11/29/2022ARWRBuy Now
Arrowhead Pharma
$12.35199.6%
Andrew Galler33%
$41 → $37MaintainsEqual-WeightGet Alert
11/10/2022IONSBuy Now
Ionis Pharmaceuticals
$28.6895.26%
Andrew Galler33%
$57 → $56MaintainsOverweightGet Alert
11/10/2022IMCRBuy Now
Immunocore Hldgs
$26.92193.46%
Andrew Galler33%
$72 → $79MaintainsOverweightGet Alert
11/08/2022FOLDBuy Now
Amicus Therapeutics
$7.05112.83%
Andrew Galler33%
$14 → $15MaintainsEqual-WeightGet Alert
11/04/2022VIRBuy Now
Vir Biotechnology
$5.57223.16%
Andrew Galler33%
$15 → $18MaintainsUnderweightGet Alert
10/13/2022IMCRBuy Now
Immunocore Hldgs
$26.92167.46%
Andrew Galler33%
$77 → $72MaintainsOverweightGet Alert
09/09/2022VIRBuy Now
Vir Biotechnology
$5.57169.3%
Andrew Galler33%
 → $15Initiates → UnderweightGet Alert
09/09/2022PTCTBuy Now
PTC Therapeutics
$45.0819.79%
Andrew Galler33%
 → $54Initiates → Equal-WeightGet Alert
09/09/2022IMCRBuy Now
Immunocore Hldgs
$26.92186.03%
Andrew Galler33%
 → $77Initiates → OverweightGet Alert
09/09/2022IONSBuy Now
Ionis Pharmaceuticals
$28.6898.74%
Andrew Galler33%
$30 → $57UpgradeUnderweight → OverweightGet Alert
09/09/2022HALOBuy Now
Halozyme Therapeutics
$61.29-18.42%
Andrew Galler33%
 → $50Initiates → OverweightGet Alert
09/09/2022ARWRBuy Now
Arrowhead Pharma
$12.35231.98%
Andrew Galler33%
 → $41Initiates → Equal-WeightGet Alert
09/09/2022FOLDBuy Now
Amicus Therapeutics
$7.0598.64%
Andrew Galler33%
 → $14Initiates → Equal-WeightGet Alert
11/09/2021MRNABuy Now
Moderna
$26.651040.71%
Andrew Galler33%
 → $304Initiates → OutperformGet Alert
11/09/2021ADCTBuy Now
ADC Therapeutics
$1.213536.36%
Andrew Galler33%
 → $44Initiates → OutperformGet Alert

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved